| Popis: |
In recent years, the development of artificial intelligence technology has gradually deepened its impact on clinical trials. It has greatly improved the efficiency of new drug research and development, significantly reduced costs and increased efficiency and has become one of the important driving forces for pharmaceutical enterprises to accelerate innovation and transformation. This protocol is for a scoping review that aims to map, describe and summarize the current status of AI use in recruitment and retention process in clincal trials, as well as identify the strengths and weaknesses of AI application in optimizing recruitment and retention in clinical trials and provide suggestions for future AI developments and clinical trials. |
